| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 424 / 428 | 1st | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Tumor Diagnostik und Therapie
Tumor Diagnostik und Therapie is Scopus-indexed (Q4, CiteScore 0). It is covered by India's One Nation One Subscription scheme for reading access. Published by Georg Thieme Verlag.
Checked against the index lists dated .
ISSN 0722-219XVerify ISSN ↗1439-1279Verify ISSN ↗
Publisher: Georg Thieme Verlag
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Tumor Diagnostik und Therapie indexed in Scopus?
Yes — actively indexed in Scopus, coverage 1983–present, best quartile Q4, CiteScore 0.
What quartile is Tumor Diagnostik und Therapie in Scopus?
Tumor Diagnostik und Therapie is Q4 in Oncology (rank 424 of 428), by CiteScore 2025.
What is the impact factor of Tumor Diagnostik und Therapie?
Tumor Diagnostik und Therapie is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0, quartile Q4, 1st percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.124, quartile Q4, with an H-index of 6.
Who publishes Tumor Diagnostik und Therapie and what is its ISSN?
Tumor Diagnostik und Therapie is published by Georg Thieme Verlag. Its print ISSN is 0722-219X and its online ISSN is 1439-1279.
Is Tumor Diagnostik und Therapie covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Tumor Diagnostik und Therapie in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Tumor Diagnostik und Therapie open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Tumor Diagnostik und Therapie? — open metrics via OpenAlex
Tumor Diagnostik und Therapie has an h-index of 8 and a 2-year mean of 0.03 citations per paper (OpenAlex). Its Scopus CiteScore is 0, quartile Q4. On 2-year citations it ranks #399 of 424 Scopus journals in Oncology.
Tumor Diagnostik und Therapie published 218 papers in 2025; its busiest recent year was 2018 with 234. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Tumor Diagnostik und Therapie? — latest 15 articles, 2026
In its latest 15 research articles (2026), authors are most often from Germany (90%), Austria (6.7%) and Portugal (3.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Tumor Diagnostik und Therapie? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
- Author concentration90% of recent authorship from Germany
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.